| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 07/02/2008 | EP1939209A1 Process for production of lipid a analogue |
| 07/02/2008 | CN100398554C Linker compound, ligand, and producing method thereof |
| 07/01/2008 | US7393937 N-acetylglucosamine derivatives and use thereof |
| 06/26/2008 | WO2008075983A2 Analogues of phosphatidylinositol mannosides |
| 06/26/2008 | WO2008075959A1 Diagnostic marker for fabry disease |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | CA2662506A1 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 06/25/2008 | EP1934388A1 Method of drug design |
| 06/25/2008 | EP1934236A1 Heterobifunctional pan-selectin inhibitors |
| 06/25/2008 | CN101208351A Compounds for the treatment of non-autoimmune type 2 diabetes mellitus and/or syndrome x |
| 06/25/2008 | CN101205245A Method for preparing hydrochloric acid clindamycinum |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390825 Process for the preparation of oxazolidinones and method of use thereof |
| 06/19/2008 | WO2008071009A1 Novel ligand guided block copolymers for targeted drug delivery |
| 06/19/2008 | WO2008049974A8 Peptide vaccine for influenza virus |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146458 Process for the preparation of oxazolidinones and method of use thereof |
| 06/19/2008 | DE10085149B4 Verfahren zur Herstellung von Acarbose mit hohem Reinheitsgrad A process for preparing acarbose with high purity |
| 06/18/2008 | EP1931359A2 Combination therapy for controlled carbohydrate digestion |
| 06/18/2008 | CN101200480A Rebaudioside A and extraction method thereof |
| 06/18/2008 | CN100395255C Ammonia maleate rubicin salt, and its preparing method and use |
| 06/18/2008 | CN100395254C High purity pharmaceutical stevioside preparation method |
| 06/18/2008 | CN100395253C Method for preparing open loop secoisolariciresinol diglucoside from flax seed |
| 06/17/2008 | US7388083 4'-keto derivative; treating N-Trifluoroacetyldaunorubicin with dimethylsulfoxide activated by different acylating agents, then with a strong tertiary amine base; fewer steps and protective groups; stereospecific and increased selectivity |
| 06/17/2008 | US7387999 Simmondsin for use as angiogenesis inhibitor |
| 06/17/2008 | US7387805 soybean saponin and/or malonyl isoflavone glycoside; a food or drink, a medicine, a cosmetic, an oral preparation, a dentifrice, an aromatic agent, a deodorant, detergent |
| 06/17/2008 | CA2260768C Methods for producing sphingolipids and sphingolipid derivatives |
| 06/17/2008 | CA2253113C Carbohydrate derivatives |
| 06/17/2008 | CA2107463C Totipotent hematopoietic stem cell receptors and their ligands |
| 06/12/2008 | WO2008069303A1 Method for production of furanose derivative |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139490 Rate of dissolution; ease of handling; storage stability; release profile; powder X-ray diffraction pattern peaks at 6.4, 9.9 and 13.2 degrees 2 theta +-0.2 degrees 2 theta; infrared spectrum peaks at 3544, 1732, and 1009 cm-1 |
| 06/11/2008 | CN101198616A Method for the synthesis of anthocyanins |
| 06/11/2008 | CN101195647A Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof |
| 06/11/2008 | CN101195646A Production method of stilbene glycoside extract |
| 06/10/2008 | US7385051 Detection and quantitation of DNA and RNA in biological genetic material; useful as fluorescent probes of nucleic acids, adenosine- and adenine nucleotide-binding proteins; N2,N3-etheno-adenosine (tetrahydro-2-(hydroxyl-methyl)-5-(4-(amino)-1H-imidazo[2,1-e]purin-1-yl)furan-3,4-diol |
| 06/10/2008 | US7385043 Homogeneous multiplex screening assays and kits |
| 06/10/2008 | US7384980 Derivatives of 3,3-diphenylpropylamines |
| 06/10/2008 | US7384904 Carboxyalkylating an alkyl or alkenyl oligoglycoside with a halocarboxylic acid or salt and heating to 50-120 degrees C. at a pH of 10-14 to reduce the content of residual halocarbon compounds to a range of 30 ppm |
| 06/10/2008 | US7384763 detecting beta-D-ribofuranosidase activity using novel chromogenic beta-D-ribofuranoside substrates such as catechol-beta-D-ribofuranoside or 3',4'-dihydroxyflavone-4'-beta-D-dibofuranoside; kits |
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/05/2008 | WO2008067039A2 Colchicine neoglycosides and methods for their synthesis and use |
| 06/05/2008 | US20080132689 Labile Linkage for Compound Delivery to a Cell |
| 06/05/2008 | US20080132458 (8S,10S)-10-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione |
| 06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/04/2008 | CN101193903A Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
| 06/04/2008 | CN101190932A Method for preparing high purity maltitol crystal powder |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/03/2008 | CA2225382C Sialic acid derivatives |
| 05/29/2008 | WO2008062842A1 Sodium salt of disaccharide compound, method for producing the same, and use of the same |
| 05/29/2008 | US20080125380 Fatty acid-anticancer conjugates and uses thereof |
| 05/29/2008 | US20080125350 Branched polyalkylene glycols |
| 05/29/2008 | CA2669674A1 Sodium salt of disaccharide compound, method for producing the same, and use of the same |
| 05/28/2008 | EP1778709B1 Polysulfated glycosides and salts thereof |
| 05/28/2008 | EP0886639B1 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES |
| 05/28/2008 | CN100390187C Method for preparing alkyl glycoside |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378398 Administering a sulfoquinovosylacylglycerol; uterine cancer, breast cancer or pancreas adenocarcinoma cancer |
| 05/22/2008 | US20080119415 Therapy and prophylaxis of infectious disease, autoimmune disease or allergic condition by administering monophosphoryl lipid a (mpl) and a l-seryl aminoalkyl glucosaminide phosphate compound (agp) |
| 05/22/2008 | US20080119414 alkyl and/or alkenyl oligoglycoside, and cationic alkyl and/or alkenyl oligoglycoside derivatives; chemical synthesis; oligosaccharide derivatives use in cosmetic wipes for cleaning, mildness towards the skin and hair and excellent foaming and emulsification properties |
| 05/22/2008 | CA2669401A1 Functionalized beta 1,6 glucosamine disaccharides and process for their preparation |
| 05/22/2008 | CA2669230A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof |
| 05/22/2008 | CA2666103A1 Glycomimetic replacements for hexoses and n-acetyl hexosamines |
| 05/21/2008 | EP1681296B1 Epimeredi glycoside a, the formulation containing thereof and their preparation method |
| 05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
| 05/21/2008 | DE102006054213A1 Homogeneous phase acetalation of oligo- or polysaccharide, e.g. for production of acid-crosslinkable cellulose acetals, by reaction with vinyl ether in solution in ionic liquid |
| 05/21/2008 | CN201062243Y Automatic discharging system for preparing weak transparent alkyl glycoside |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375213 inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example dapagliflozin |
| 05/20/2008 | US7375095 Sugar derivative |
| 05/20/2008 | US7375090 inhibitory effect on sodium-dependent glucose cotransporter; for the treatment of diseases, particularly metabolic disorders such as diabetes; e.g. 1-(2-propyn-1-yl)-3-( beta -D-glucopyranosyloxy)-4-(4-ethylbenzyl)-5-methyl-1H-pyrazole |
| 05/20/2008 | US7375088 culture product from a Streptomyces aizunensis strain; inhibitors of fungal cell growth and cancer cell growth; for lowering serum cholesterol and other steroids |
| 05/20/2008 | US7375087 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 05/20/2008 | CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2169621C Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 05/15/2008 | US20080113923 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent |
| 05/15/2008 | DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer |
| 05/15/2008 | DE102006053637A1 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted with fluorine 1,4-benzothiepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053635A1 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |
| 05/14/2008 | CN101177440A Method for rapid purification of codonopsis pilosula lobetyolin monomer from codonopsis pilosula medicinal materials |
| 05/14/2008 | CN101177439A Preparation of kilogram-grade scale high-purity monosialotetrahexosylganglioside |
| 05/14/2008 | CN101177438A N-acetylglucosamine derivatives and use thereof |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371733 Paranmycin antibiotics with activity against resistant bacterial strains equipped with aminoglycoside modifying enzymes. |
| 05/13/2008 | US7371732 for inhibiting the sodium-dependent glucose cotransporter; 1-( beta -D-glucopyranosyloxy)-2-[4-((R)-tetrahydrofuran-3-yloxy)benzyl]-benzene, 1-( beta -D-glucopyranosyloxy)-2-(4-ethynylbenzyl)-benzene |
| 05/13/2008 | US7371730 Crystals of glucopyranosyloxybenzyl benzene derivative |
| 05/08/2008 | WO2008054892A2 Chitin micro-particles as an adjuvant |
| 05/08/2008 | US20080108800 Selective reduction of spinosyn factors Et-J and Et-L to spinetoram |
| 05/08/2008 | US20080108580 1-Bromo-4-deoxy-4-fluoro-2,3,6-tri-O-acetyl-alpha-D-galactose derivatives; antidiabetic agent |
| 05/07/2008 | EP1049707B1 Ustilipides, method for the production and the use thereof |
| 05/07/2008 | CN101175499A Use of lipid conjugates in the treatment of disease |
| 05/07/2008 | CN101172955A Diamine anti-cancer medicine |
| 05/07/2008 | CN100386338C Monkshood aglycone and homolog, Preparing method thereof and medicinal composition using said compound as active substance |
| 05/06/2008 | US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 05/06/2008 | CA2279795C Methods of making an emulsified composition |
| 05/02/2008 | WO2008052077A2 Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst |